Our three keynote speakers will, we are sure, inspire us all. Their presentations will focus on behaviour change and issues of addiction. The established role of pharmacists in substance misuse (tobacco and drugs) and their emerging role in managing excessive alcohol consumption, make

these presentations particularly relevant to the conference theme and selleck kinase inhibitor audience. In advance of the conference we would like to thank everyone who has already contributed in various ways, illustrating how successful team working can be! We thank those who have submitted scientific abstracts, the HSRPP steering committee, Pharmacy Research UK, the University of Aberdeen CPD Services Unit, and all our sponsors.  Special thanks go to the Society for the Study of Addictions which has sponsored the substance misuse workshop, including a networking lunch, and two prizes for the best substance misuse-related presentation and poster. Finally, we hope these two days will be productive and enjoyable for both new and experienced researchers. “
“Objective  To examine the views of regular pharmacy clients on pharmacist prescribing and employ agency theory in considering the relationship between the stakeholders involved. Methods  Computer assisted telephone interviews were conducted with 400 pharmacy clients recruited around Australia. Potential respondents

were identified using BMS-354825 mw a random number generation function in Microsoft Excel. Data were analysed with SPSS version 17 using one-way analysis of variance, principal component analysis and linear regression. The relationships between the main stakeholders involved were explored

using agency theory. Key findings  A total of 1153 answered calls recruited 400 consenting pharmacy clients. Most respondents (71%) trusted pharmacists adopting an expanded role in prescribing, however the majority (66%) supported this only after a diagnosis had been made by a doctor. Those who accepted pharmacist diagnosing and prescribing preferred that this was limited to pain management and antibiotics. Most respondents (64%) considered that expanded pharmacist prescribing would improve their access to prescription medicines, although those over 65 years of age were less supportive than Ponatinib younger respondents. Factors which contributed positively to clients’ perception of trust in an expanded prescribing role for pharmacists were identified, and improved access to medicines was found to be the strongest predictor (P < 0.0001). Conclusion  Most pharmacy clients trusted pharmacists adopting an expanded prescribing role, but preferred that this was limited to doctors performing the initial diagnosis. Agency theory would conceptualize the introduction of pharmacist prescribers, as disrupting the principal (patient) agent (doctor) relationship. Its introduction would best be facilitated by careful change management. "
“Reporting of adverse drug reactions (ADRs) may differ between countries.